Clinical Cancer Research Prevention Award Frontiers in Basic Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Allard, W. J.
Right arrow Articles by Terstappen, L. W. M. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Allard, W. J.
Right arrow Articles by Terstappen, L. W. M. M.
Clinical Cancer Research Vol. 10, 6897-6904, October 15, 2004
© 2004 American Association for Cancer Research

Molecular Oncology, Markers, Clinical Correlates

Tumor Cells Circulate in the Peripheral Blood of All Major Carcinomas but not in Healthy Subjects or Patients With Nonmalignant Diseases

W. Jeffrey Allard1, Jeri Matera1, M. Craig Miller1, Madeline Repollet1, Mark C. Connelly1, Chandra Rao1, Arjan G. J. Tibbe1, Jonathan W. Uhr2 and Leon W. M. M. Terstappen1

1 Immunicon Corporation, Huntingdon Valley, Pennsylvania; and 2 Cancer Immunobiology Center and Departments of Microbiology, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas

Purpose: The purpose of this study was to determine the accuracy, precision, and linearity of the CellSearch system and evaluate the number of circulating tumor cells (CTCs) per 7.5 mL of blood in healthy subjects, patients with nonmalignant diseases, and patients with a variety of metastatic carcinomas.

Experimental Design: The CellSearch system was used to enumerate CTCs in 7.5 mL of blood. Blood samples spiked with cells from tumor cell lines were used to establish analytical accuracy, reproducibility, and linearity. Prevalence of CTCs was determined in blood from 199 patients with nonmalignant diseases, 964 patients with metastatic carcinomas, and 145 healthy donors.

Results: Enumeration of spiked tumor cells was linear over the range of 5 to 1,142 cells, with an average recovery of ≥85% at each spike level. Only 1 of the 344 (0.3%) healthy and nonmalignant disease subjects had ≥2 CTCs per 7.5 mL of blood. In 2,183 blood samples from 964 metastatic carcinoma patients, CTCs ranged from 0 to 23,618 CTCs per 7.5 mL (mean, 60 ± 693 CTCs per 7.5 mL), and 36% (781 of 2,183) of the specimens had ≥2 CTCs. Detection of ≥2 CTCs occurred at the following rates: 57% (107 of 188) of prostate cancers, 37% (489 of 1,316) of breast cancers, 37% (20 of 53) of ovarian cancers, 30% (99 of 333) of colorectal cancers, 20% (34 of 168) of lung cancers, and 26% (32 of 125) of other cancers.

Conclusions: The CellSearch system can be standardized across multiple laboratories and may be used to determine the clinical utility of CTCs. CTCs are extremely rare in healthy subjects and patients with nonmalignant diseases but present in various metastatic carcinomas with a wide range of frequencies.




This article has been cited by other articles:


Home page
 Ann OncolHome page
S. J. Cohen, C. J. A. Punt, N. Iannotti, B. H. Saidman, K. D. Sabbath, N. Y. Gabrail, J. Picus, M. A. Morse, E. Mitchell, M. C. Miller, et al.
Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer
Ann. Onc., July 1, 2009; 20(7): 1223 - 1229.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
O. B. Goodman Jr., L. M. Fink, J. T. Symanowski, B. Wong, B. Grobaski, D. Pomerantz, Y. Ma, D. C. Ward, and N. J. Vogelzang
Circulating Tumor Cells in Patients with Castration-Resistant Prostate Cancer Baseline Values and Correlation with Prognostic Factors
Cancer Epidemiol. Biomarkers Prev., June 1, 2009; 18(6): 1904 - 1913.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
Y. Okumura, F. Tanaka, K. Yoneda, M. Hashimoto, T. Takuwa, N. Kondo, and S. Hasegawa
Circulating Tumor Cells in Pulmonary Venous Blood of Primary Lung Cancer Patients.
Ann. Thorac. Surg., June 1, 2009; 87(6): 1669 - 1675.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
P. Pajer, V. Karafiat, V. Pecenka, D. Prukova, J. Dudlova, J. Plachy, P. Kasparova, and M. Dvorak
Industasis, a Promotion of Tumor Formation by Nontumorigenic Stray Cells
Cancer Res., June 1, 2009; 69(11): 4605 - 4612.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
M. A. Leversha, J. Han, Z. Asgari, D. C. Danila, O. Lin, R. Gonzalez-Espinoza, A. Anand, H. Lilja, G. Heller, M. Fleisher, et al.
Fluorescence In situ Hybridization Analysis of Circulating Tumor Cells in Metastatic Prostate Cancer
Clin. Cancer Res., March 15, 2009; 15(6): 2091 - 2097.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
A. H. Talasaz, A. A. Powell, D. E. Huber, J. G. Berbee, K.-H. Roh, W. Yu, W. Xiao, M. M. Davis, R. F. Pease, M. N. Mindrinos, et al.
Isolating highly enriched populations of circulating epithelial cells and other rare cells from blood using a magnetic sweeper device
PNAS, March 10, 2009; 106(10): 3970 - 3975.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
D. J. Gallagher, M. I. Milowsky, N. Ishill, A. Trout, M. G. Boyle, J. Riches, M. Fleisher, and D. F. Bajorin
Detection of circulating tumor cells in patients with urothelial cancer
Ann. Onc., February 1, 2009; 20(2): 305 - 308.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
C. Massard, A. Chauchereau, and K. Fizazi
The quest for the 'bony Grail' of detecting circulating tumour cells in patients with prostate cancer
Ann. Onc., February 1, 2009; 20(2): 197 - 199.
[Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
S. C. C. Wong, C. M. L. Chan, B. B. Y. Ma, E. P. Hui, S. S. M. Ng, P. B. S. Lai, M. T. Cheung, E. S. F. Lo, A. K. C. Chan, M. Y. Y. Lam, et al.
Clinical Significance of Cytokeratin 20-Positive Circulating Tumor Cells Detected by a Refined Immunomagnetic Enrichment Assay in Colorectal Cancer Patients
Clin. Cancer Res., February 1, 2009; 15(3): 1005 - 1012.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
T. M. Morgan, P. H. Lange, M. P. Porter, D. W. Lin, W. J. Ellis, I. S. Gallaher, and R. L. Vessella
Disseminated Tumor Cells in Prostate Cancer Patients after Radical Prostatectomy and without Evidence of Disease Predicts Biochemical Recurrence
Clin. Cancer Res., January 15, 2009; 15(2): 677 - 683.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
A. M. Sieuwerts, J. Kraan, J. Bolt, P. van der Spoel, F. Elstrodt, M. Schutte, J. W. M. Martens, J.-W. Gratama, S. Sleijfer, and J. A. Foekens
Anti-Epithelial Cell Adhesion Molecule Antibodies and the Detection of Circulating Normal-Like Breast Tumor Cells
J Natl Cancer Inst, January 7, 2009; 101(1): 61 - 66.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
D. Olmos, H.-T. Arkenau, J. E. Ang, I. Ledaki, G. Attard, C. P. Carden, A. H. M. Reid, R. A'Hern, P. C. Fong, N. B. Oomen, et al.
Circulating tumour cell (CTC) counts as intermediate end points in castration-resistant prostate cancer (CRPC): a single-centre experience
Ann. Onc., January 1, 2009; 20(1): 27 - 33.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
C. M. Sturgeon, M. J. Duffy, U.-H. Stenman, H. Lilja, N. Brunner, D. W. Chan, R. Babaian, R. C. Bast Jr., B. Dowell, F. J. Esteva, et al.
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Testicular, Prostate, Colorectal, Breast, and Ovarian Cancers
Clin. Chem., December 1, 2008; 54(12): e11 - e79.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
K. Hiraiwa, H. Takeuchi, H. Hasegawa, Y. Saikawa, K. Suda, T. Ando, K. Kumagai, T. Irino, T. Yoshikawa, S. Matsuda, et al.
Clinical Significance of Circulating Tumor Cells in Blood from Patients with Gastrointestinal Cancers
Ann. Surg. Oncol., November 1, 2008; 15(11): 3092 - 3100.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
J.-Y. Pierga, F.-C. Bidard, C. Mathiot, E. Brain, S. Delaloge, S. Giachetti, P. de Cremoux, R. Salmon, A. Vincent-Salomon, and M. Marty
Circulating Tumor Cell Detection Predicts Early Metastatic Relapse After Neoadjuvant Chemotherapy in Large Operable and Locally Advanced Breast Cancer in a Phase II Randomized Trial
Clin. Cancer Res., November 1, 2008; 14(21): 7004 - 7010.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
J. S. de Bono, H. I. Scher, R. B. Montgomery, C. Parker, M. C. Miller, H. Tissing, G. V. Doyle, L. W.W.M. Terstappen, K. J. Pienta, and D. Raghavan
Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer
Clin. Cancer Res., October 1, 2008; 14(19): 6302 - 6309.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
C. Alix-Panabieres, S. Riethdorf, and K. Pantel
Circulating Tumor Cells and Bone Marrow Micrometastasis
Clin. Cancer Res., August 15, 2008; 14(16): 5013 - 5021.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
S. Maheswaran, L. V. Sequist, S. Nagrath, L. Ulkus, B. Brannigan, C. V. Collura, E. Inserra, S. Diederichs, A. J. Iafrate, D. W. Bell, et al.
Detection of Mutations in EGFR in Circulating Lung-Cancer Cells
N. Engl. J. Med., July 24, 2008; 359(4): 366 - 377.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J.-P. Eliane, M. Repollet, K. E. Luker, M. Brown, J. M. Rae, G. Dontu, A. F. Schott, M. Wicha, G. V. Doyle, D. F. Hayes, et al.
Monitoring Serial Changes in Circulating Human Breast Cancer Cells in Murine Xenograft Models
Cancer Res., July 15, 2008; 68(14): 5529 - 5532.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
S. J. Cohen, C. J.A. Punt, N. Iannotti, B. H. Saidman, K. D. Sabbath, N. Y. Gabrail, J. Picus, M. Morse, E. Mitchell, M. C. Miller, et al.
Relationship of Circulating Tumor Cells to Tumor Response, Progression-Free Survival, and Overall Survival in Patients With Metastatic Colorectal Cancer
J. Clin. Oncol., July 1, 2008; 26(19): 3213 - 3221.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
D. F. Hayes and J. Smerage
Is There a Role for Circulating Tumor Cells in the Management of Breast Cancer?
Clin. Cancer Res., June 15, 2008; 14(12): 3646 - 3650.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
F. Nole, E. Munzone, L. Zorzino, I. Minchella, M. Salvatici, E. Botteri, M. Medici, E. Verri, L. Adamoli, N. Rotmensz, et al.
Variation of circulating tumor cell levels during treatment of metastatic breast cancer: prognostic and therapeutic implications
Ann. Onc., May 1, 2008; 19(5): 891 - 897.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
J. Sastre, M. L. Maestro, J. Puente, S. Veganzones, R. Alfonso, S. Rafael, J. A. Garcia-Saenz, M. Vidaurreta, M. Martin, M. Arroyo, et al.
Circulating tumor cells in colorectal cancer: correlation with clinical and pathological variables
Ann. Onc., May 1, 2008; 19(5): 935 - 938.
[Abstract] [Full Text] [PDF]

Home page
 aacredbookHome page
K. Pantel, C. Alix-Panabieres, and S. Riethdorf
Circulating Tumor Cells: Detection and Clinical Relevance
Am. Assoc. Cancer Res. Educ. Book, April 12, 2008; 2008(1): 603 - 610.
[Abstract] [Full Text] [PDF]

Home page
 aacredbookHome page
M C. Miller, G. V Doyle, and L. W M M Terstappen
Monitoring and Characterization of CTC in Cancer Patients
Am. Assoc. Cancer Res. Educ. Book, April 12, 2008; 2008(1): 617 - 624.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
C. E. Reed, A. Graham, R. S. Hoda, A. Khoor, E. Garrett-Mayer, M. B. Wallace, and M. Mitas
A simple two-gene prognostic model for adenocarcinoma of the lung
J. Thorac. Cardiovasc. Surg., March 1, 2008; 135(3): 627 - 634.
[Abstract] [Full Text] [PDF]

Home page
 Am Soc Clin Oncol Ed BookHome page
C. P. Carden, D. Olmos, and J. S. de Bono
Validated and Qualified Biomarkers Are Critical to Optimizing Anticancer Drug Development: Potential Roles for the Study of Circulating Tumor Cells
ASCO Educational Book, January 1, 2008; 2008(1): 166 - 170.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
D. C. Danila, G. Heller, G. A. Gignac, R. Gonzalez-Espinoza, A. Anand, E. Tanaka, H. Lilja, L. Schwartz, S. Larson, M. Fleisher, et al.
Circulating Tumor Cell Number and Prognosis in Progressive Castration-Resistant Prostate Cancer
Clin. Cancer Res., December 1, 2007; 13(23): 7053 - 7058.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
P. Haluska, H. M. Shaw, G. N. Batzel, D. Yin, J. R. Molina, L. R. Molife, T. A. Yap, M. L. Roberts, A. Sharma, A. Gualberto, et al.
Phase I Dose Escalation Study of the Anti Insulin-Like Growth Factor-I Receptor Monoclonal Antibody CP-751,871 in Patients with Refractory Solid Tumors
Clin. Cancer Res., October 1, 2007; 13(19): 5834 - 5840.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
W. He, H. Wang, L. C. Hartmann, J.-X. Cheng, and P. S. Low
In vivo quantitation of rare circulating tumor cells by multiphoton intravital flow cytometry
PNAS, July 10, 2007; 104(28): 11760 - 11765.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
J. S. de Bono, G. Attard, A. Adjei, M. N. Pollak, P. C. Fong, P. Haluska, L. Roberts, C. Melvin, M. Repollet, D. Chianese, et al.
Potential Applications for Circulating Tumor Cells Expressing the Insulin-Like Growth Factor-I Receptor
Clin. Cancer Res., June 15, 2007; 13(12): 3611 - 3616.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. Saudemont, A. Hamrouni, P. Marchetti, J. Liu, N. Jouy, D. Hetuin, F. Colucci, and B. Quesnel
Dormant Tumor Cells Develop Cross-Resistance to Apoptosis Induced by CTLs or Imatinib Mesylate via Methylation of Suppressor of Cytokine Signaling 1
Cancer Res., May 1, 2007; 67(9): 4491 - 4498.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
D. R. Shaffer, M. A. Leversha, D. C. Danila, O. Lin, R. Gonzalez-Espinoza, B. Gu, A. Anand, K. Smith, P. Maslak, G. V. Doyle, et al.
Circulating Tumor Cell Analysis in Patients with Progressive Castration-Resistant Prostate Cancer
Clin. Cancer Res., April 1, 2007; 13(7): 2023 - 2029.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
S. Riethdorf, H. Fritsche, V. Muller, T. Rau, C. Schindlbeck, B. Rack, W. Janni, C. Coith, K. Beck, F. Janicke, et al.
Detection of Circulating Tumor Cells in Peripheral Blood of Patients with Metastatic Breast Cancer: A Validation Study of the CellSearch System
Clin. Cancer Res., February 1, 2007; 13(3): 920 - 928.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
G. T. Budd, M. Cristofanilli, M. J. Ellis, A. Stopeck, E. Borden, M. C. Miller, J. Matera, M. Repollet, G. V. Doyle, L. W.M.M. Terstappen, et al.
Circulating Tumor Cells versus Imaging--Predicting Overall Survival in Metastatic Breast Cancer.
Clin. Cancer Res., November 1, 2006; 12(21): 6403 - 6409.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
D. F. Hayes, M. Cristofanilli, G. T. Budd, M. J. Ellis, A. Stopeck, M. C. Miller, J. Matera, W. J. Allard, G. V. Doyle, and L. W.W.M. Terstappen
Circulating Tumor Cells at Each Follow-up Time Point during Therapy of Metastatic Breast Cancer Patients Predict Progression-Free and Overall Survival.
Clin. Cancer Res., July 15, 2006; 12(14): 4218 - 4224.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
N. L. Henry and D. F. Hayes
Uses and abuses of tumor markers in the diagnosis, monitoring, and treatment of primary and metastatic breast cancer.
Oncologist, June 1, 2006; 11(6): 541 - 552.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
M. Mimeault and S. K. Batra
Recent advances on multiple tumorigenic cascades involved in prostatic cancer progression and targeting therapies
Carcinogenesis, January 1, 2006; 27(1): 1 - 22.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
H. I. Scher and C. L. Sawyers
Biology of Progressive, Castration-Resistant Prostate Cancer: Directed Therapies Targeting the Androgen-Receptor Signaling Axis
J. Clin. Oncol., November 10, 2005; 23(32): 8253 - 8261.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
C. Alix-Panabieres, X. Rebillard, J.-P. Brouillet, E. Barbotte, F. Iborra, B. Segui, T. Maudelonde, C. Jolivet-Reynaud, and J.-P. Vendrell
Detection of Circulating Prostate-Specific Antigen-Secreting Cells in Prostate Cancer Patients
Clin. Chem., August 1, 2005; 51(8): 1538 - 1541.
[Full Text] [PDF]

Home page
 Cancer Res.Home page
D. A. Smirnov, D. R. Zweitzig, B. W. Foulk, M. C. Miller, G. V. Doyle, K. J. Pienta, N. J. Meropol, L. M. Weiner, S. J. Cohen, J. G. Moreno, et al.
Global Gene Expression Profiling of Circulating Tumor Cells
Cancer Res., June 15, 2005; 65(12): 4993 - 4997.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
M. M. Reinholz, A. Nibbe, L. M. Jonart, K. Kitzmann, V. J. Suman, J. N. Ingle, R. Houghton, B. Zehentner, P. C. Roche, and W. L. Lingle
Evaluation of a Panel of Tumor Markers for Molecular Detection of Circulating Cancer Cells in Women with Suspected Breast Cancer
Clin. Cancer Res., May 15, 2005; 11(10): 3722 - 3732.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
M. Fiegl, H. Denz, I. H. Kunkler, C. Tang, A. Y. Lin, A. C. Voogd, K. van Gestel, M. F. Ernst, M. Cristofanilli, L. W.M.M. Terstappen, et al.
Circulating Epithelial Cells in Breast Cancer
N. Engl. J. Med., December 2, 2004; 351(23): 2452 - 2454.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2004 by the American Association for Cancer Research.